Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safeÅsa Wickberg, Kenneth Villman, Göran Liljegren et al.|European Journal of Surgical Oncology|2018Cited by 21
Omission of postoperative radiotherapy after breast-conserving surgery in low-risk breast cancerSofia Palmér, Kenneth Villman, Antonios Valachis et al.|JNCI Journal of the National Cancer Institute|2024Cited by 2
Abstract P1-10-05: Omitting radiotherapy in women ≥ 65 years with early breast cancer and favorable histopathology after breast-conserving surgery, sentinel node biopsy and adjuvant endocrine therapy is safeKKA Villman, Göran Liljegren, Åsa Wickberg et al.|Cancer Research|2017Cited by 0
PREDIX II HER2: Improving pre-operative systemic therapy for human epidermal growth factor receptor 2 (HER2) amplified breast cancer (BC).Renske Kornalijnslijper-Altena, Jonas Bergh, Anne Andersson et al.|Journal of Clinical Oncology|2020Cited by 0